Table 2 Complication and organ failure odds ratio of AP patients in different treatment groups after propensity score matching
From: Current diagnosis and treatment of acute pancreatitis in China: a real-world, multicenter study
Variables | Complication | Organ failure | ||||
|---|---|---|---|---|---|---|
Event (%) | OR (95% CI) | p | Event (%) | OR (95% CI) | p | |
Somatostatin | 19 (3.3) | 1 (ref) | 11 (1.9) | 1 (ref) | ||
Octreotide | 52 (9.1) | 2.91 (1.69, 4.99) | < 0.001 | 27 (4.7) | 2.53 (1.24, 5.14) | 0.011 |
Somatostatin | 40(6.3) | 1 (ref) | 25 (3.9) | 1 (ref) | ||
Somatostatin + Octreotide | 65(10.2) | 1.70 (1.12,2.56) | 0.011 | 38 (6.0) | 1.55 (0.93,2.61) | 0.093 |